Ancora Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
VCM
VPM
Ancora Advisors's BSX Position: Q1 2026 in Review
Ancora Advisors increased its Boston Scientific (BSX) stake by 21% in Q1 2026, buying an estimated $114K and bringing the position to 8,052 shares worth $505K. The position accounts for 0.01% of the portfolio, ranked #525.
Ancora Advisors first reported a position in BSX in Q3 2018 and has held it in 20 quarters since. The position peaked at $632K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Ancora Advisors held 8,052 shares of Boston Scientific worth $505K as of Q1 2026.
- Ancora Advisors bought 1,421 Boston Scientific shares in Q1 2026, an estimated $114K.
- Boston Scientific made up 0.01% of Ancora Advisors's portfolio in Q1 2026, its #525 holding.
- Ancora Advisors first reported a position in Boston Scientific in Q3 2018 and has held it in 20 quarters since.
- Ancora Advisors's Boston Scientific position peaked at $632K in Q4 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.